VanEck Biotech ETF (NASDAQ:BBH) Sees Large Increase in Short Interest

VanEck Biotech ETF (NASDAQ:BBH – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 60,902 shares, a growth of 51.2% from the October 15th total of 40,268 shares. Currently, 3.0% of the company’s shares are short sold. Based on an average daily trading volume, of 14,685 shares, the short-interest ratio is presently 4.1 days.

VanEck Biotech ETF Stock Down 0.7%

Shares of BBH stock traded down $1.73 during trading on Wednesday, hitting $246.05. 12,140 shares of the stock traded hands, compared to its average volume of 8,157. The firm’s fifty day moving average price is $244.49 and its 200-day moving average price is $210.30. VanEck Biotech ETF has a 52-week low of $179.25 and a 52-week high of $263.74.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Nwam LLC acquired a new stake in shares of VanEck Biotech ETF during the second quarter valued at about $18,614,000. LGL Partners LLC purchased a new stake in shares of VanEck Biotech ETF in the 2nd quarter valued at approximately $2,298,000. Proficio Capital Partners LLC purchased a new stake in shares of VanEck Biotech ETF in the 2nd quarter valued at approximately $5,183,000. Segall Bryant & Hamill LLC purchased a new stake in shares of VanEck Biotech ETF in the 1st quarter valued at approximately $881,000. Finally, Quantitative Investment Management LLC acquired a new position in shares of VanEck Biotech ETF in the 2nd quarter worth approximately $7,589,000. 32.05% of the stock is currently owned by hedge funds and other institutional investors.

VanEck Biotech ETF Company Profile

(Get Free Report)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

See Also

Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.